Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax Pharmaceutical Investing
Obalon Therapeutics Announces Two Agreements To Provide Up To $30 Million of Capital Medical Device Investing
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology Medical Device Investing
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets Biotech Investing
